Sesen Bio, Inc. Uncategorized Contracts & Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Open Market Sale AgreementSM, dated as of May 12, 2023, by and between the Company and Jefferies LLC
Sesen Bio, Inc.
Biotechnology
NY
2023
Contingent Value Rights Agreement, dated March 7, 2023
Sesen Bio, Inc.
Biotechnology
DE
2023
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Sesen Bio, Inc.
Biotechnology
2022
Amendment No
Sesen Bio, Inc.
Biotechnology
2021
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Sesen Bio, Inc.
Biotechnology
2021
Amendment No. 2 to the Open Market Sale Agreement
Sesen Bio, Inc.
Biotechnology
2021
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Sesen Bio, Inc.
Biotechnology
2020
Open Market Sale AgreementSM, dated November 29, 2019, by and between Sesen Bio, Inc. and Jefferies LLC
Sesen Bio, Inc.
Biotechnology
NY
2019
Placement Agent Agreement, dated as of March 21, 2018 by and between Eleven Biotherapeutics, Inc. and Laidlaw & Company (UK) Ltd
Sesen Bio, Inc.
Biotechnology
NY
2018
- 2 -
Sesen Bio, Inc.
Biotechnology
MA
2016
- 2 -
Sesen Bio, Inc.
Biotechnology
MA
2016
ALMAD INVESTMENTS LIMITED (hereinafter called the Landlord),
Sesen Bio, Inc.
Biotechnology
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Sesen Bio, Inc.
Biotechnology
DE
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Sesen Bio, Inc.
Biotechnology
2016
ELEVEN BIOTHERAPEUTICS, INC. (A corporation existing under the laws of the State of Delaware)
Sesen Bio, Inc.
Biotechnology
2014
Eleven Biotherapeutics, Inc.
Sesen Bio, Inc.
Biotechnology
NY
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Sesen Bio, Inc.
Biotechnology
MA
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
Sesen Bio, Inc.
Biotechnology
MA
2013